• Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury

    25 days ago - By San Diego Biotechnology

    CARLSBAD, Calif.--- $LCTX CIRM-Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has entered......
    Read more ...